We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Diaceutics Plc | LSE:DXRX | London | Ordinary Share | GB00BJQTGV64 | ORD GBP0.002 |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 103.00 | 102.00 | 104.00 | 103.00 | 103.00 | 103.00 | 25,020 | 08:00:07 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Testing Laboratories | 19.5M | 724k | 0.0086 | 119.77 | 87.01M |
From Apr 2022 to Apr 2024
TIDMDXRX
RNS Number : 3117O
Diaceutics PLC
30 January 2023
30 January 2023
Diaceutics PLC
("Diaceutics" or "the Company")
PDMR Shareholding/Share Incentive Plan
Diaceutics PLC , ( AIM: DXRX), a leading technology and solutions provider to the pharmaceutical industry, has been notified that on 27 January 2023, Global Shares Trustees (UK) Limited and Zedra Trust Company (Guernsey) Limited, the trustees of the Global Diaceutics plc 2020 Employee Benefit Trust , have purchased ordinary shares ("Shares") on behalf of Stefan McDonald, Susanne Munksted, Jordan Clark, Julie Browne and Nick Roberts (PDMRs), in respect of their purchase of Shares pursuant to the Company's UK and Global Share Incentive Plan ("the SIP Schemes") for employees . These purchases will be made each month until further notice.
In accordance with the SIP Schemes, the Company has matched these purchases with a matched share award over an equivalent number of Shares purchased by the employee, in the proportion of 1:1.
Enquiries:
Hot Features
Premium
Diaceutics PLC
Nick Roberts, Chief Financial Officer Via Alma PR
Stifel Nicolaus Europe Limited (Nomad & Broker) Tel: +44 (0)20 7710
7600
Ben Maddison
Stewart Wallace
Nick Adams
Alma PR Tel: +44(0)20 3405
0205
Caroline Forde diaceutics@almapr.co.uk
Kieran Breheny
Matthew Young
Kinvara Verdon
About Diaceutics
At Diaceutics we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome. We provide the world's leading pharmaceutical and life science companies with solutions and technology for the commercialisation of their precision medicines, enabled by the proprietary DXRX platform.
DXRX is the world's first diagnostic commercialisation platform for precision medicine, utilising a global network of affiliate laboratories to deliver multiple pipelines of real-world healthcare data insights, advisory services and innovative platform enabled solutions.
Notification of a Transaction pursuant to Article 19(1) of Regulation
(EU) No. 596/2014
1 Details of the person discharging managerial responsibilities/person
closely associated
---- -----------------------------------------------------------------------------------
a. Name Stefan McDonald
------------------------------------------------------
2 Reason for notification
--------------------------- ------------------------------------------------------
a. Position/Status Chief Growth Officer and PDMR
--------------------------- ------------------------------------------------------
b. Initial notification/ Initial
Amendment
------------------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a. Name Diaceutics PLC
---------------------------
b. LEI 213800VEWQBB39ZB8J81
--------------------------- ------------------------------------------------------
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
---- -----------------------------------------------------------------------------------
a. Description of Ordinary shares of GBP 0.002 each
the financial
instrument, type ISIN: GB00BJQTGV64
of instrument
Identification
Code
--------------------------- ------------------------------------------------------
b. Nature of the Ongoing non-discretionary purchase of Shares
transaction matched by the grant of conditional share
award over Shares under the Diaceutics plc
UK Share Incentive Plan ("SIP")
--------------------------- ------------------------------------------------------
c. Price(s) and volume(s) Share purchase:
--------------------------- ----------------------------- --- ----------
Price(s) Volume(s)
--------------------------- ------------
0.98 p 153
------------ ----------------
Matched share award:
------------------------------
Price(s) Volume(s)
------------
0.98 p 153
------------ ----------------
e. Date of the transaction Share purchase and Matched Share award:
27 January 2023
--------------------------- ------------------------------------------------------
f. Place of the transaction Share Purchase and Matched Share Award:
AIM Market of the London Stock Exchange
--------------------------- ------------------------------------------------------
Notification of a Transaction pursuant to Article 19(1) of Regulation
(EU) No. 596/2014
1 Details of the person discharging managerial responsibilities/person
closely associated
---- -----------------------------------------------------------------------------------
a. Name Susanne Munksted
------------------------------------------------------
2 Reason for notification
--------------------------- ------------------------------------------------------
a. Position/Status Chief Precision Medicine Officer and PDMR
--------------------------- ------------------------------------------------------
b. Initial notification/ Initial
Amendment
------------------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a. Name Diaceutics PLC
---------------------------
b. LEI 213800VEWQBB39ZB8J81
--------------------------- ------------------------------------------------------
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
---- -----------------------------------------------------------------------------------
a. Description of Ordinary shares of GBP 0.002 each
the financial
instrument, type ISIN: GB00BJQTGV64
of instrument
Identification
Code
--------------------------- ------------------------------------------------------
b. Nature of the Ongoing non-discretionary purchase of Shares
transaction matched by the grant of conditional share
award over Shares under the Global Share
Incentive Plan ("SIP")
--------------------------- ------------------------------------------------------
c. Price(s) and volume(s) Share purchase:
--------------------------- ----------------------------- --- ----------
Price(s) Volume(s)
--------------------------- ------------
0.98 p 155
------------ ----------------
Conditional share award:
------------------------------
Price(s) Volume(s)
------------
Nil 155
------------ ----------------
e. Date of the transaction Share purchase and Conditional share award:
27 January 2023
--------------------------- ------------------------------------------------------
f. Place of the transaction Share Purchase: AIM Market of the London
Stock Exchange
Conditional share award: Off-Market
--------------------------- ------------------------------------------------------
Notification of a Transaction pursuant to Article 19(1) of Regulation
(EU) No. 596/2014
1 Details of the person discharging managerial responsibilities/person
closely associated
---- -----------------------------------------------------------------------------------
a. Name Jordan Clark
------------------------------------------------------
2 Reason for notification
--------------------------- ------------------------------------------------------
a. Position/Status Chief Commercial Officer and PDMR
--------------------------- ------------------------------------------------------
b. Initial notification/ Initial
Amendment
------------------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a. Name Diaceutics PLC
---------------------------
b. LEI 213800VEWQBB39ZB8J81
--------------------------- ------------------------------------------------------
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
---- -----------------------------------------------------------------------------------
a. Description of Ordinary shares of GBP 0.002 each
the financial
instrument, type ISIN: GB00BJQTGV64
of instrument
Identification
Code
--------------------------- ------------------------------------------------------
b. Nature of the Ongoing non-discretionary purchase of Shares
transaction matched by the grant of conditional share
award over Shares under the Diaceutics plc
UK Share Incentive Plan ("SIP")
--------------------------- ------------------------------------------------------
c. Price(s) and volume(s) Share purchase:
--------------------------- ----------------------------- --- ----------
Price(s) Volume(s)
--------------------------- ------------
0.98 p 153
------------ ----------------
Matched share award:
------------------------------
Price(s) Volume(s)
------------
0.98 p 153
------------ ----------------
e. Date of the transaction Share purchase and Matched Share award:
27 January 2023
--------------------------- ------------------------------------------------------
f. Place of the transaction Share Purchase and Matched Share Award:
AIM Market of the London Stock Exchange
--------------------------- ------------------------------------------------------
Notification of a Transaction pursuant to Article 19(1) of Regulation
(EU) No. 596/2014
1 Details of the person discharging managerial responsibilities/person
closely associated
---- -----------------------------------------------------------------------------------
a. Name Julie Browne
------------------------------------------------------
2 Reason for notification
--------------------------- ------------------------------------------------------
a. Position/Status Chief Operations Officer and PDMR
--------------------------- ------------------------------------------------------
b. Initial notification/ Initial
Amendment
------------------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a. Name Diaceutics PLC
---------------------------
b. LEI 213800VEWQBB39ZB8J81
--------------------------- ------------------------------------------------------
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
---- -----------------------------------------------------------------------------------
a. Description of Ordinary shares of GBP 0.002 each
the financial
instrument, type ISIN: GB00BJQTGV64
of instrument
Identification
Code
--------------------------- ------------------------------------------------------
b. Nature of the Ongoing non-discretionary purchase of Shares
transaction matched by the grant of conditional share
award over Shares under the Diaceutics plc
UK Share Incentive Plan ("SIP")
--------------------------- ------------------------------------------------------
c. Price(s) and volume(s) Share purchase:
--------------------------- ----------------------------- --- ----------
Price(s) Volume(s)
--------------------------- ------------
0.98 p 153
------------ ----------------
Matched share award:
------------------------------
Price(s) Volume(s)
------------
0.98 p 153
------------ ----------------
e. Date of the transaction Share purchase and Matched Share award:
27 January 2023
--------------------------- ------------------------------------------------------
f. Place of the transaction Share Purchase and Matched Share Award:
AIM Market of the London Stock Exchange
--------------------------- ------------------------------------------------------
Notification of a Transaction pursuant to Article 19(1) of Regulation
(EU) No. 596/2014
1 Details of the person discharging managerial responsibilities/person
closely associated
---- -----------------------------------------------------------------------------------
a. Name Nick Roberts
------------------------------------------------------
2 Reason for notification
--------------------------- ------------------------------------------------------
a. Position/Status Chief Finance Officer and PDMR
--------------------------- ------------------------------------------------------
b. Initial notification/ Initial
Amendment
------------------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a. Name Diaceutics PLC
---------------------------
b. LEI 213800VEWQBB39ZB8J81
--------------------------- ------------------------------------------------------
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
---- -----------------------------------------------------------------------------------
a. Description of Ordinary shares of GBP 0.002 each
the financial
instrument, type ISIN: GB00BJQTGV64
of instrument
Identification
Code
--------------------------- ------------------------------------------------------
b. Nature of the Ongoing non-discretionary purchase of Shares
transaction matched by the grant of conditional share
award over Shares under the Diaceutics plc
UK Share Incentive Plan ("SIP")
--------------------------- ------------------------------------------------------
c. Price(s) and volume(s) Share purchase:
--------------------------- ----------------------------- --- ----------
Price(s) Volume(s)
--------------------------- ------------
0.98 p 153
------------ ----------------
Matched share award:
------------------------------
Price(s) Volume(s)
------------
0.98 p 153
------------ ----------------
e. Date of the transaction Share purchase and Matched Share award:
27 January 2023
--------------------------- ------------------------------------------------------
f. Place of the transaction Share Purchase and Matched Share Award:
AIM Market of the London Stock Exchange
--------------------------- ------------------------------------------------------
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHSDWFWSEDSESF
(END) Dow Jones Newswires
January 30, 2023 12:11 ET (17:11 GMT)
1 Year Diaceutics Chart |
1 Month Diaceutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
